📰 Opgn News
Page 3 - Opgn News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Opgn. Real-time updates on events, politics, business and more.
September 13, 2023
StockNews.com assumed coverage on shares of OpGen (NASDAQ:OPGN – Free Report) in a research note released on Saturday. The brokerage issued a hold rating on the medical research company’s stock. Separately, HC Wainwright cut OpGen from a buy rating to a neutral rating in a report on Monday, August 14th. Check Out Our Latest Research […]
September 12, 2023
StockNews.com started coverage on shares of OpGen (NASDAQ:OPGN – Free Report) in a report published on Saturday. The brokerage issued a hold rating on the medical research company’s stock. Separately, HC Wainwright downgraded shares of OpGen from a buy rating to a neutral rating in a report on Monday, August 14th. View Our Latest Stock […]
September 11, 2023
Equities researchers at StockNews.com started coverage on shares of OpGen (NASDAQ:OPGN – Get Free Report) in a report released on Saturday. The brokerage set a “hold” rating on the medical research company’s stock. Separately, HC Wainwright cut shares of OpGen from a “buy” rating to a “neutral” rating in a research report on Monday, August […]
September 5, 2023
StockNews.com started coverage on shares of OpGen (NASDAQ:OPGN – Free Report) in a research report released on Friday. The firm issued a hold rating on the medical research company’s stock. Separately, HC Wainwright cut shares of OpGen from a buy rating to a neutral rating in a report on Monday, August 14th. Read Our Latest […]
September 4, 2023
StockNews.com initiated coverage on shares of OpGen (NASDAQ:OPGN – Free Report) in a report issued on Friday. The brokerage issued a hold rating on the medical research company’s stock. Separately, HC Wainwright downgraded shares of OpGen from a buy rating to a neutral rating in a research note on Monday, August 14th. Get Our Latest […]
September 2, 2023
StockNews.com initiated coverage on shares of OpGen (NASDAQ:OPGN – Free Report) in a report issued on Friday morning. The brokerage issued a hold rating on the medical research company’s stock. Separately, HC Wainwright cut OpGen from a buy rating to a neutral rating in a research note on Monday, August 14th. View Our Latest Stock […]
August 27, 2023
StockNews.com began coverage on shares of OpGen (NASDAQ:OPGN – Free Report) in a research note released on Thursday morning. The brokerage issued a hold rating on the medical research company’s stock. Separately, HC Wainwright downgraded OpGen from a buy rating to a neutral rating in a report on Monday, August 14th. View Our Latest Analysis […]
August 26, 2023
OpGen, Inc. (NASDAQ:OPGN – Get Free Report) was the recipient of a significant growth in short interest in August. As of August 15th, there was short interest totalling 168,000 shares, a growth of 123.1% from the July 31st total of 75,300 shares. Based on an average daily volume of 307,700 shares, the days-to-cover ratio is […]
August 20, 2023
StockNews.com began coverage on shares of OpGen (NASDAQ:OPGN – Free Report) in a report published on Wednesday morning. The firm issued a hold rating on the medical research company’s stock. Separately, HC Wainwright downgraded shares of OpGen from a buy rating to a neutral rating in a research note on Monday, August 14th. View Our […]
August 16, 2023
OpGen, Inc. (NASDAQ:OPGN – Free Report) – Investment analysts at HC Wainwright decreased their Q3 2023 earnings per share (EPS) estimates for shares of OpGen in a report issued on Monday, August 14th. HC Wainwright analyst Y. Chen now expects that the medical research company will post earnings per share of ($0.43) for the quarter, […]